These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 10565786)

  • 1. Fluorodeoxyglucose imaging to assess myocardial viability: PET, SPECT or gamma camera coincidence imaging?
    Bax JJ; Wijns W
    J Nucl Med; 1999 Nov; 40(11):1893-5. PubMed ID: 10565786
    [No Abstract]   [Full Text] [Related]  

  • 2. PET versus SPECT for determining myocardial tissue viability using fluorine-18-fluorodeoxyglucose.
    Schraml FV; Driver DR; Randolph T; Silverman ED
    J Nucl Med Technol; 1997 Dec; 25(4):272-4. PubMed ID: 9438929
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Validity of 18F-fluorodeoxyglucose imaging with a dual-head coincidence gamma camera for detection of myocardial viability.
    Hasegawa S; Uehara T; Yamaguchi H; Fujino K; Kusuoka H; Hori M; Nishimura T
    J Nucl Med; 1999 Nov; 40(11):1884-92. PubMed ID: 10565785
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Myocardial viability assessment with FDG imaging: comparison of PET, SPECT, and gamma-camera coincidence detection.
    Kerrou K; Toussaint JF; Froissart M; Talbot JN
    J Nucl Med; 2000 Dec; 41(12):2099. PubMed ID: 11138698
    [No Abstract]   [Full Text] [Related]  

  • 5. Comparison of fluorine-18-FDG with rest-redistribution thallium-201 SPECT to delineate viable myocardium and predict functional recovery after revascularization.
    Bax JJ; Cornel JH; Visser FC; Fioretti PM; van Lingen A; Huitink JM; Elhendy A; Poldermans D; Roelandt JR; Visser CA
    J Nucl Med; 1998 Sep; 39(9):1481-6. PubMed ID: 9744328
    [No Abstract]   [Full Text] [Related]  

  • 6. Nuclear cardiology, Part IV: Viability.
    Mesotten L; Maes A; Hambye AS; Everaert H; Van den Maegdenbergh V; Franken P; Mortelmans L
    J Nucl Med Technol; 1999 Jun; 27(2):93-102; quiz 104-5. PubMed ID: 10353105
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fluorine-18-fluorodeoxyglucose cardiac imaging using a modified scintillation camera.
    Sandler MP; Bax JJ; Patton JA; Visser FC; Martin WH; Wijns W
    J Nucl Med; 1998 Dec; 39(12):2035-43. PubMed ID: 9867138
    [TBL] [Abstract][Full Text] [Related]  

  • 8. F-18 fluoro deoxyglucose SPECT for assessment of myocardial viability.
    Fitzgerald J; Parker JA; Danias PG
    J Nucl Cardiol; 2000; 7(4):382-7. PubMed ID: 10958281
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thallium scintigraphy compared with 18F-fluorodeoxyglucose positron emission tomography for assessing myocardial viability in patients with moderate versus severe left ventricular dysfunction.
    Marin-Neto JA; Dilsizian V; Arrighi JA; Perrone-Filardi P; Bacharach SL; Bonow RO
    Am J Cardiol; 1998 Nov; 82(9):1001-7. PubMed ID: 9817471
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fluorine-18-deoxyglucose SPECT and coincidence imaging for myocardial viability: Clinical and technologic issues.
    Dilsizian V; Bacharach SL; Khin MM; Smith MF
    J Nucl Cardiol; 2001; 8(1):75-88. PubMed ID: 11182712
    [No Abstract]   [Full Text] [Related]  

  • 11. [Potential and limitation of myocardial perfusion scintigraphy for detection of viability].
    Knapp WH
    Nuklearmedizin; 1995 Jun; 34(3):118-26. PubMed ID: 7630745
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Myocardial viability assessment using nuclear imaging.
    Matsunari I; Taki J; Nakajima K; Tonami N; Hisada K
    Ann Nucl Med; 2003 May; 17(3):169-79. PubMed ID: 12846538
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Viability in chronic ischaemic cardiomyopathy: need for timely revascularisation.
    Chareonthaitawee P; Barnes E; Rimoldi O; Camici PG; Burke MM; Khaghani A
    Eur J Nucl Med; 1999 Nov; 26(11):1521-2. PubMed ID: 10627177
    [No Abstract]   [Full Text] [Related]  

  • 14. Myocardial ischemia, fluorodeoxyglucose, and severity of coronary artery stenosis: the complexities of metabolic remodeling in hibernating myocardium.
    Gould KL; Taegtmeyer H
    Circulation; 2004 Mar; 109(12):e167-70; author reply e167-70. PubMed ID: 15051653
    [No Abstract]   [Full Text] [Related]  

  • 15. Coronary artery bypass surgery as treatment for ischemic heart failure: the predictive value of viability assessment with quantitative positron emission tomography for symptomatic and functional outcome.
    Pagano D; Townend JN; Littler WA; Horton R; Camici PG; Bonser RS
    J Thorac Cardiovasc Surg; 1998 Apr; 115(4):791-9. PubMed ID: 9576212
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of myocardial ischemia using a rest metabolism/stress perfusion protocol with fluorine-18 deoxyglucose/technetium-99m MIBI and dual-isotope simultaneous-acquisition single-photon emission computed tomography.
    Sandler MP; Videlefsky S; Delbeke D; Patton JA; Meyerowitz C; Martin WH; Ohana I
    J Am Coll Cardiol; 1995 Oct; 26(4):870-8. PubMed ID: 7560611
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Discordant pattern, visual identification of myocardial viability with PET].
    Alexánderson E; Ricalde A; Zerón J; Talayero JA; Cruz P; Adame G; Mendoza G; Meave A
    Arch Cardiol Mex; 2006; 76(4):347-54. PubMed ID: 17315610
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of the clinical value of combination of 99mTc-MIBI myocardial SPECT and 18F-FDG PET in assessing myocardial viability.
    Zhang X; Liu X; Shi R; Wu Q; Gao R; Liu Y; Hu S; Guo S; Xie F; Li Y
    Radiat Med; 1999; 17(3):205-10. PubMed ID: 10440109
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Myocardial SPECT in the study of ischemic heart disease detection of hibernating myocardium and evaluation of cost/benefit ratio.
    Giordano A; Calcagni ML; Verrillo A; Maccafeo S
    Rays; 1999; 24(1):73-80. PubMed ID: 10358385
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of myocardial viability with F-18-fluorodeoxyglucose and single photon emission computed tomography.
    Bax JJ; Valkema R; Visser FC; Poldermans D; Cornel JH; van Lingen A; Krenning EP; Rambaldi R; Roelandt JR; Visser CA; Fioretti PM
    G Ital Cardiol; 1997 Nov; 27(11):1181-6. PubMed ID: 9419825
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.